This webinar will discuss the FDA requirements and guidelines for investigating Out-of-trend (OOT) results in the pharmaceutical laboratory. It will also cover FDA-compliant documentation of OOT, failure investigations, root causes, and CAPA.
WHY SHOULD YOU ATTEND?
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
AREA COVERED
- FDA regulations and guidelines.
- FDA's final Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production.
- Difference between OOS and OOT results.
- Developing SOPs for OOT situations and laboratory failures.
- Investigating OOT results: what and how.
- Retesting of OOT results.
- Using historical data for OOT evaluation.
- Using QC samples and product control charts for evaluation.
- Developing corrective and preventive action plans.
- Finding the root cause for OOT results.
- Strategies to avoid OOS situations BEFORE they occur.
- FDA-compliant documentation of OOS, OOT, failure investigations, root causes, and CAPA.
WHO WILL BENEFIT?
- Lab Supervisors and Managers
- QA managers and personnel
- Pharmaceutical R&D personnel
- Documentation
- Consultants
- Contract laboratories
- CROs
FDA's guidance on OOS test results requires failure investigations and other steps for Out-of-Specification (OOS) and Out-of-trend (OOT) results. While most companies are familiar with and have procedures for OOS results, this is not the case for OOT situations. The guide states: "Although the subject of this document is OOS results, much of the guidance may be useful for examining results that are out of trend". Managing OOT results also helps to avoid time-consuming OOS results. The industry is unsure how to interpret and implement the FDA guidance.
This session will equip you with the knowledge and comprehensive understanding of FDA requirements for Out-of-Trend Results in pharmaceutical quality control.
- FDA regulations and guidelines.
- FDA's final Guidance for Industry: Investigating Out-of-Specification (OOS) Test Results for Pharmaceutical Production.
- Difference between OOS and OOT results.
- Developing SOPs for OOT situations and laboratory failures.
- Investigating OOT results: what and how.
- Retesting of OOT results.
- Using historical data for OOT evaluation.
- Using QC samples and product control charts for evaluation.
- Developing corrective and preventive action plans.
- Finding the root cause for OOT results.
- Strategies to avoid OOS situations BEFORE they occur.
- FDA-compliant documentation of OOS, OOT, failure investigations, root causes, and CAPA.
- Lab Supervisors and Managers
- QA managers and personnel
- Pharmaceutical R&D personnel
- Documentation
- Consultants
- Contract laboratories
- CROs
Speaker Profile

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.
Upcoming Webinars

2025 Handbook Overhaul: Navigating Critical Updates! Federa…


Dealing With Difficult People In Life & Work

Harassment, Bullying, Gossip, Confrontational and Disruptiv…

Copilot and HR: An Introduction for HR Professionals

Beat Workplace Burnout: 10 Proven Techniques to Manage Your…

Workplace Investigations Uncovered: Best Practices and Stra…

Employers Should Prepare for Immigration Raids in 2025! Thi…

Managing Toxic Employees: Strategies For Leaders To Effecti…


Keys to Captivating an Audience: Informing and Inspiring t…

Do's and Don'ts of Documenting Employee Behaviour, Performa…

Understanding Artificial Intelligence (AI) & using Chat GPT

Transform Data into Insights: A Beginners Guide to Excel Pi…

Empowering Conflict Resolution: Letting Go to Gain Control


Outlook - Master your Mailbox - Inbox Hero Inbox Zero

Bootcamp for New Managers and Supervisors: Develop These Es…

Project Management for administrative professionals

Negotiating Skills For Professional Results - Winning Strat…

How to Write Effective Audit Observations: The Principles f…


How to Use ChatGPT to Write Employee Evaluations


Power BI - Getting Started Building Reports and Dashboards

3-Hour Virtual Boot Camp on Easier Excel Automation with VB…


Onboarding is NOT Orientation - How to Improve the New Empl…

How to Conduct Exit Interviews - Implementing and Enhancing…

Onboarding Best Practices for 2025: Proven Strategies to Po…

Form W-9 Compliance: TIN Verification, B Notices, and Avoid…

The Five Cs Of Commercial Credit: The Basic Elements Of Cre…

2025 EEOC & Employers: Investigating Claims of Harassment …

2-Hour Virtual Seminar on How to Conduct an Internal Harass…